Can Magnetic Brain Stimulation Stop Post-Surgery Delirium in Elderly Patients?

A new clinical trial is testing whether repetitive transcranial magnetic stimulation (rTMS) can prevent delirium in elderly patients after joint replacement surgery. The study, led by Zhao Zj., Yang Y., Wei Sr., and colleagues, aims to move beyond treating symptoms and instead stop delirium before it starts.

Delirium—a sudden confusion and loss of attention—commonly affects older adults following arthroplasty. If successful, this approach could improve recovery and ease pressure on families and hospitals. The trial is a single-centre, randomised investigation. Elderly patients scheduled for joint replacement will be carefully selected and split into two groups: one receiving active rTMS treatment, the other a placebo-like sham procedure.

rTMS is a non-surgical method that uses magnetic pulses to adjust brain activity. Researchers have fine-tuned the technique’s frequency, strength, and brain targets based on the latest neuroscience. The goal is to stabilise brain function during the vulnerable postoperative period.

Safety remains a priority, with close monitoring for side effects like headaches or scalp irritation. The team recognises that delirium has many causes, so rTMS may work best as part of a broader care plan rather than a standalone solution.

By focusing on prevention rather than reaction, the study could change how postoperative delirium is managed in older patients. If rTMS proves effective, it may significantly reduce delirium cases in elderly arthroplasty patients. This could lead to better recovery experiences, less burden on carers, and lower demands on healthcare resources. The trial’s findings will determine whether the technique becomes a standard part of perioperative care.